Literature DB >> 22492136

Controlled human blood stage malaria infection: current status and potential applications.

Christopher J A Duncan1, Simon J Draper.   

Abstract

Controlled human malaria infection by blood stage parasite (BSP) inoculation is an alternative to the well-established model of infection with Plasmodium falciparum sporozoites delivered by mosquito bites. The BSP model has been utilized less frequently, but its use is increasing. Advantages of BSP challenge include greater ease of administration, better standardization of the infecting dose per volunteer, and good inter-study reproducibility of in vivo parasite dynamics. Recently, a surprising reduction in clinical symptoms at microscopic patency in the BSP model has been identified, which has an undefined and intriguing pathophysiologic basis, but may make this approach more acceptable to volunteers. We summarize clinical, parasitologic, and immunologic data from all BSP challenges to date, explore differences between the BSP and sporozoite models, and propose future applications for BSP challenge.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492136      PMCID: PMC3403771          DOI: 10.4269/ajtmh.2012.11-0504

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines.

Authors:  Q Cheng; G Lawrence; C Reed; A Stowers; L Ranford-Cartwright; A Creasey; R Carter; A Saul
Journal:  Am J Trop Med Hyg       Date:  1997-10       Impact factor: 2.345

2.  Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.

Authors:  M D Edstein; B M Kotecka; K L Anderson; D J Pombo; D E Kyle; K H Rieckmann; M F Good
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity during primary infection.

Authors:  W E Collins; G M Jeffery
Journal:  Am J Trop Med Hyg       Date:  1999-07       Impact factor: 2.345

4.  A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccines.

Authors:  D A Herrington; D F Clyde; J R Murphy; S Baqar; M M Levine; V do Rosario; M R Hollingdale
Journal:  Trop Geogr Med       Date:  1988-04

5.  Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers.

Authors:  G Lawrence; Q Q Cheng; C Reed; D Taylor; A Stowers; N Cloonan; C Rzepczyk; A Smillie; K Anderson; D Pombo; A Allworth; D Eisen; R Anders; A Saul
Journal:  Vaccine       Date:  2000-03-17       Impact factor: 3.641

6.  Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.

Authors:  David J Pombo; Gregor Lawrence; Chakrit Hirunpetcharat; Christine Rzepczyk; Michelle Bryden; Nicole Cloonan; Karen Anderson; Yuvadee Mahakunkijcharoen; Laura B Martin; Danny Wilson; Salenna Elliott; Suzanne Elliott; Damon P Eisen; J Brice Weinberg; Allan Saul; Michael F Good
Journal:  Lancet       Date:  2002-08-24       Impact factor: 79.321

7.  A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites.

Authors:  Olivier Silvie; Jean-François Franetich; Stéphanie Charrin; Markus S Mueller; Anthony Siau; Myriam Bodescot; Eric Rubinstein; Laurent Hannoun; Yupin Charoenvit; Clemens H Kocken; Alan W Thomas; Geert-Jan Van Gemert; Robert W Sauerwein; Michael J Blackman; Robin F Anders; Gerd Pluschke; Dominique Mazier
Journal:  J Biol Chem       Date:  2003-12-15       Impact factor: 5.157

8.  Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction.

Authors:  Cornelus C Hermsen; Sake J de Vlas; Geert Jan A van Gemert; Denise S C Telgt; Danielle F Verhage; Robert W Sauerwein
Journal:  Am J Trop Med Hyg       Date:  2004-08       Impact factor: 2.345

9.  Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites.

Authors:  Philip Bejon; Laura Andrews; Rikke F Andersen; Susanna Dunachie; Daniel Webster; Michael Walther; Sarah C Gilbert; Tim Peto; Adrian V S Hill
Journal:  J Infect Dis       Date:  2005-01-07       Impact factor: 5.226

10.  A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs.

Authors:  James S McCarthy; Silvana Sekuloski; Paul M Griffin; Suzanne Elliott; Nanette Douglas; Chris Peatey; Rebecca Rockett; Peter O'Rourke; Louise Marquart; Cornelius Hermsen; Stephan Duparc; Jörg Möhrle; Katharine R Trenholme; Andrew J Humberstone
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

View more
  26 in total

Review 1.  Vaccines to Accelerate Malaria Elimination and Eventual Eradication.

Authors:  Julie Healer; Alan F Cowman; David C Kaslow; Ashley J Birkett
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

Review 2.  Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy?

Authors:  Christopher J A Duncan; Adrian V S Hill; Ruth D Ellis
Journal:  Hum Vaccin Immunother       Date:  2012-04-20       Impact factor: 3.452

Review 3.  Controlled Human Malaria Infection: Applications, Advances, and Challenges.

Authors:  Danielle I Stanisic; James S McCarthy; Michael F Good
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

4.  Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.

Authors:  James S McCarthy; Paul M Griffin; Silvana Sekuloski; A Taylor Bright; Rebecca Rockett; David Looke; Suzanne Elliott; David Whiley; Theo Sloots; Elizabeth A Winzeler; Katharine R Trenholme
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

5.  Immunosignatures can predict vaccine efficacy.

Authors:  Joseph Barten Legutki; Stephen Albert Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

6.  Mapping immune variation and var gene switching in naive hosts infected with Plasmodium falciparum.

Authors:  Kathryn Milne; Alasdair Ivens; Adam J Reid; J Alexandra Rowe; Philip J Spence; Magda E Lotkowska; Aine O'Toole; Geetha Sankaranarayanan; Diana Munoz Sandoval; Wiebke Nahrendorf; Clement Regnault; Nick J Edwards; Sarah E Silk; Ruth O Payne; Angela M Minassian; Navin Venkatraman; Mandy J Sanders; Adrian Vs Hill; Michael Barrett; Matthew Berriman; Simon J Draper
Journal:  Elife       Date:  2021-03-02       Impact factor: 8.140

Review 7.  Progress towards the development of a P. vivax vaccine.

Authors:  Sai Lata De; Francis B Ntumngia; Justin Nicholas; John H Adams
Journal:  Expert Rev Vaccines       Date:  2021-03-04       Impact factor: 5.217

8.  Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.

Authors:  Ruth O Payne; Kathryn H Milne; Sean C Elias; Nick J Edwards; Alexander D Douglas; Rebecca E Brown; Sarah E Silk; Sumi Biswas; Kazutoyo Miura; Rachel Roberts; Thomas W Rampling; Navin Venkatraman; Susanne H Hodgson; Geneviève M Labbé; Fenella D Halstead; Ian D Poulton; Fay L Nugent; Hans de Graaf; Priya Sukhtankar; Nicola C Williams; Christian F Ockenhouse; April K Kathcart; Aziz N Qabar; Norman C Waters; Lorraine A Soisson; Ashley J Birkett; Graham S Cooke; Saul N Faust; Colleen Woods; Karen Ivinson; James S McCarthy; Carter L Diggs; Johan Vekemans; Carole A Long; Adrian V S Hill; Alison M Lawrie; Sheetij Dutta; Simon J Draper
Journal:  J Infect Dis       Date:  2016-02-04       Impact factor: 5.226

9.  ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.

Authors:  Susanne H Sheehy; Christopher J A Duncan; Sean C Elias; Prateek Choudhary; Sumi Biswas; Fenella D Halstead; Katharine A Collins; Nick J Edwards; Alexander D Douglas; Nicholas A Anagnostou; Katie J Ewer; Tom Havelock; Tabitha Mahungu; Carly M Bliss; Kazutoyo Miura; Ian D Poulton; Patrick J Lillie; Richard D Antrobus; Eleanor Berrie; Sarah Moyle; Katherine Gantlett; Stefano Colloca; Riccardo Cortese; Carole A Long; Robert E Sinden; Sarah C Gilbert; Alison M Lawrie; Tom Doherty; Saul N Faust; Alfredo Nicosia; Adrian V S Hill; Simon J Draper
Journal:  Mol Ther       Date:  2012-10-23       Impact factor: 11.454

10.  Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.

Authors:  Angela M Minassian; Sarah E Silk; Jordan R Barrett; Carolyn M Nielsen; Kazutoyo Miura; Ababacar Diouf; Carolin Loos; Jonathan K Fallon; Ashlin R Michell; Michael T White; Nick J Edwards; Ian D Poulton; Celia H Mitton; Ruth O Payne; Michael Marks; Hector Maxwell-Scott; Antonio Querol-Rubiera; Karen Bisnauthsing; Rahul Batra; Tatiana Ogrina; Nathan J Brendish; Yrene Themistocleous; Thomas A Rawlinson; Katherine J Ellis; Doris Quinkert; Megan Baker; Raquel Lopez Ramon; Fernando Ramos Lopez; Lea Barfod; Pedro M Folegatti; Daniel Silman; Mehreen Datoo; Iona J Taylor; Jing Jin; David Pulido; Alexander D Douglas; Willem A de Jongh; Robert Smith; Eleanor Berrie; Amy R Noe; Carter L Diggs; Lorraine A Soisson; Rebecca Ashfield; Saul N Faust; Anna L Goodman; Alison M Lawrie; Fay L Nugent; Galit Alter; Carole A Long; Simon J Draper
Journal:  Med (N Y)       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.